ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994

Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress

June 6, 1980

Surgery, Radiation Effective For Older Women, Study Finds

September 24, 2004

Called “Unscrupulous” in Abramson Lawsuit, Thompson Calls Abramson A Rich Man Scorned

March 23, 2012

DCPC BSC Committee Endorses Three Research Concepts

April 17, 1987

Grants & Contracts: NCI Workshop Informs Historically Black Institutions About Funding Process

October 10, 1997